Postmenopausal osteoporosis is associated with significant morbidity, mortality, reduction in quality of life, and increasing health care costs. It is estimated that 1.5 million women in the United States have one or more osteoporosis-related fractures annually. Fractures may occur at any site, but vertebral fractures are the most common. Longitudinal studies have demonstrated a decreased life ...

BACKGROUND Osteonecrosis of the jaw (ONJ) is an adverse effect of drugs that suppress bone turnover - for example, drugs used for the treatment of postmenopausal osteoporosis. The Danish National Registry of Patients (DNRP) is potentially valuable for monitoring ONJ and its prognosis; however, no specific code for ONJ exists in the International Classification of Diseases 10th revision (ICD-10)...

abstract introduction: adequate intake of fruits and vegetables as part of the daily diet could help prevent major non-communicable diseases including osteoporosis. some nutrients abundant in fruits and vegetables have been shown to affect bone health. in the present study we evaluated fruit and vegetable intake in postmenopausal women with osteopenia who had referred to bone mineral densitomet...

Osteoporosis or calcification of bones is a symptom that can occur in postmenopausal women. Bones with osteoporosis will become hollow, causing easy fractures. Risk factors for be hormonal, calcium intake, gender, vitamin D, physical activity, caffeine consumption, alcohol blood sugar levels, hypertension, long-term use corticosteroids, parity, nutritional status and duration menopause. The pop...

introduction: osteoporosis as a public health problem affects the quality of life of many postmenopausal women. a high concentration of zinc is found in bones. it works as a cofactor of some key enzymes essential in bone synthesis and reconstruction.having considered the importance of zinc and calcium for healthy bones and also the prevalence of zinc deficiency, this study was designed to deter...

BACKGROUND MiR-133 expression is dysregulated in postmenopausal osteoporosis. However, its role in postmenopausal osteoporosis is still not well understood. In the current study, we explore how estrogen deficiency affects miR-133 expression and how miR-133 is involved in osteogenic differentiation of mesenchymal stem cells (MSCs). MATERIAL AND METHODS qRT-PCR analysis was performed to assess ...

Objective: To update the evidence-based position statement published by The North American Menopause Society (NAMS) in 2006 regarding the management of osteoporosis in postmenopausal women. Methods: NAMS followed the general principles established for evidence-based guidelines to create this updated document. A panel of clinicians and researchers expert in the field of metabolic bone diseases a...

BACKGROUND A vast amount of literature describes the incidence of fracture as a risk for recurrent osteoporotic fractures in western and Asian countries. Osteoporosis evaluation and treatment after a low-trauma fracture, however, has not been well characterized in postmenopausal women in Asia. The purpose of this study was to characterize patient and health system characteristics associated wit...

background: in view of the current high prevalence of diabetes mellitus (dm) and osteoporosis, today there is great inter est in studying the possible association between these two disorders. the aim of this study was to determine the association be tween type-2 dm, and bone mineral density (bmd) in iranian women. methods: bmd was determined in the femoral neck and at the l2-l4 level (dexa) 0f ...

Osteoporosis is an age-related chronic disease characterized by a loss of bone mass and quality, and is associated with an increased risk of fragility fractures. Postmenopausal women are at the greatest risk of developing osteoporosis due to the cessation in ovarian hormone production, which causes accelerated bone loss. As the demographic shifts to a more aged population, a growing number of p...